Topia Technology, Inc. v. Egnyte, Inc.

District Court, D. Delaware·Decided July 6, 2023·No. 1:21-cv-01821·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE

TOPIA TECHNOLOGY, INC., ) ) Plaintiff, ) ) v. ) Civil Action No. 21-1821-CJB ) EGNYTE, INC., ) ) Defendant. )

MEMORANDUM ORDER

Pending before the Court in this patent infringement case is Plaintiff Topia Technology, Inc.’s (“Plaintiff” or “Topia”) motion to amend the Complaint (“Motion”) to add additional allegations relating to two of the original six patents-in-suit—United States Patent Nos. 9,143,561 (the “'561 patent”) and 10,067,942 (the “'942 patent,” and together with the '561 patent, the “patents at issue”). (D.I. 69) For the reasons set out below, the Motion is GRANTED. I. FACTUAL AND PROCEDURAL BACKGROUND Plaintiff filed the Complaint in this case on December 27, 2021, in which it asserted that Defendant Egnyte, Inc. (“Defendant” or “Egnyte”) infringed the two patents at issue as well as four additional patents: United States Patent Nos. 10,289,607, 10,642,787, 10,754,823 and 11,003,622 (the “four additional patents-in-suit”). (D.I. 1)1 Defendant thereafter filed a motion for judgment on the pleadings (the “MJP”), (D.I. 39); with the MJP, Defendant argued that each of the original six patents-in-suit are directed to non-patent-eligible subject matter pursuant to 35 U.S.C. § 101 (“Section 101”). At a hearing held on December 20, 2022 (the “December 2022

1 The parties consented to the Court’s jurisdiction to conduct all proceedings in the case on March 17, 2022. (D.I. 19) hearing”), the Court read its decision orally, explaining why it was granting-in-part and denying- in-part the MJP. (D.I. 68) The Court found that, based on the record before it, the two patents at issue were directed to patent-ineligible subject matter; it granted the MJP as to those patents. (Id. at 221) As to the four additional patents-in-suit, the Court denied the MJP. (Id.) The Court then

permitted Plaintiff the opportunity to seek to amend its Complaint in order to try to plausibly allege that, at step two of the Alice eligibility analysis, the claims of the patents at issue include an inventive concept. (Id. at 221-22) Thereafter, on March 31, 2023, the Court issued a written version of the decision it had provided orally during the December 2022 hearing (the “March 31, 2023 opinion”). (D.I. 91) In the March 31, 2023 opinion, the Court simply memorialized in writing what it had said at the December 2022 hearing (while also correcting transcription errors and adding supporting footnotes where appropriate). (Id.)2 Plaintiff’s Motion was filed on January 20, 2023. (D.I. 69)3 The Motion was fully briefed as of February 15, 2023. (D.I. 82) The parties are well familiar with the record and they desire a timely decision on the

Motion. In light of that, the Court will not set out herein all of the relevant facts regarding the Motion or the two patents at issue. Instead, the Court will assume familiarity with the March 31,

2 In a recent filing, Defendant stated its view that the Court’s March 31, 2023 opinion was intended to do more than simply restate the ruling the Court had made at the December 2022 hearing. (D.I. 104) Since the March 31, 2023 opinion was issued after briefing for the instant Motion had concluded, Defendant suggested that in issuing the March 31, 2023 opinion, the Court meant to also deny the instant Motion—and thus to conclude that any amendment of the Complaint as to the two patents at issue was inappropriate. (Id. at 1) Defendant is wrong. As the Court stated at the December 2022 hearing, (D.I. 68 at 224), and as it reiterated in the March 31, 2023 opinion, (D.I. 91 at 1), the March 31, 2023 opinion was simply meant to memorialize in writing what the Court had decided at the hearing, nothing more.

3 The Motion attaches a proposed Amended Complaint (which contains the new allegations) as Exhibit A to the Motion. (D.I. 70, ex. A) 2023 opinion. See Topia Tech., Inc. v. Egnyte, Inc., Civil Action No. 21-1821-CJB, 2023 WL 2734607 (D. Del. Mar. 31, 2023). And to the extent that additional facts are relevant to the Motion, the Court will set out those in Section III below. II. STANDARD OF REVIEW

Federal Rule of Civil Procedure 15(a) declares that leave to amend shall be “freely” given “when justice so requires.” Fed. R. Civ. P. 15(a). The Supreme Court of the United States has explained that this mandate “is to be heeded” and that in the “absence of any apparent or declared reason—such as undue delay, bad faith or dilatory motive on the part of the movant, repeated failure to cure deficiencies by amendments previously allowed, undue prejudice to the opposing party by virtue of allowance of the amendment, futility of amendment, etc.—the leave sought should, as the rules require, be ‘freely given.’” Foman v. Davis, 371 U.S. 178, 182 (1962) (citation omitted). In opposing the Motion, Defendant primarily relies on its claim that granting the Motion would be a futile act. This is assertedly because even taking into account the new allegations in

the proposed Amended Complaint, Plaintiff cannot plausibly allege that the patents at issue are patent eligible. (D.I. 78) In assessing futility with regard to a motion to amend, the Court “applies the same standard of legal sufficiency as applies under [Federal] Rule [of Civil Procedure] 12(b)(6).” City of Cambridge Ret. Sys. v. Altisource Asset Mgmt. Corp., 908 F.3d 872, 878 (3d Cir. 2018). III. DISCUSSION In its March 31, 2023 opinion, as to the two patents at issue, the Court ruled that: (1) at step one of the Alice test for eligibility, the record demonstrated that the representative claims of the patents were directed to the abstract idea put forward by Defendant: “synchronizing multiple versions of [a] file across network computers”; and (2) Plaintiff had not plausibly demonstrated that, at step two of the analysis, the claims otherwise contained an inventive concept, sufficient to withstand dismissal. (D.I. 91 at 4-13) In its step two analysis, the Court further explained that it was “hard to see what more there is in [representative] claim 1 of [the '561 patent] beyond” the

abstract idea because “[a]ll or nearly all of the claim’s language seems to be focused on the general concept of automatically transferring modified electronic files between network devices.” (Id. at 8) The Court also noted that Plaintiff “did not add allegations to its [C]omplaint that address[] the [Section] 101 question at [s]tep [two] in a manner that might suggest otherwise.” (Id.) And with regard to representative claim 5 of the '942 patent, which is similar to claim 1 of the '561 patent (with the exception of the addition of certain “determining” steps),4 the Court noted that Plaintiff did not make any arguments at step two that were specific to the determining steps. With the instant Motion, Plaintiff focuses on step two of the Alice framework.5 There Plaintiff asserts that in the Amended Complaint, it has added allegations that plausibly indicate

patent eligibility. (D.I. 70 at 2 (“The Complaint is amended to recite factual allegations that

4 These “determining” steps cause the claimed system to determine whether or not two electronic devices are in communication with each other before sending modified electronic files from one device to another. ('942 patent, col. 11:3-4, 19-20, 59-63)

Free access — add to your briefcase to read the full text and ask questions with AI

Topia Technology, Inc. v. Egnyte, Inc., (D. Del. 2023).

Topia Technology, Inc. v. Egnyte, Inc. (Topia Technology, Inc. v. Egnyte, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Foman v. Davis
371 U.S. 178 (Supreme Court, 1962)
Thales Visionix Inc. v. United States
850 F.3d 1343 (Federal Circuit, 2017)
Cellspin Soft, Inc. v. Fitbit, Inc.
927 F.3d 1306 (Federal Circuit, 2019)